System

New concept session for {{entity:Pharmaceutical Manufacturing Line}} ({{hex:55F73A59}}), an automated continuous manufacturing line for oral solid dosage forms. This system produces tablets and capsules at commercial scale (100k–500k units per batch) in a GMP-compliant cleanroom, with real-time release testing via process analytical technology (PAT). The engineering challenge centres on balancing production throughput against three competing safety domains: patient safety (product quality), occupational safety (potent compound containment), and process safety (dust explosion prevention). The step fusion power plant system was marked complete this session after validation in session 544.

ConOps

Six operating modes defined: Startup/Qualification ({{hex:40953A58}}), Normal Production ({{hex:54E53218}}), Degraded Production ({{hex:40941A19}}), Changeover/Cleaning ({{hex:40953A58}}), Emergency Stop ({{hex:40B57A51}}), and Preventive Maintenance ({{hex:40843A58}}). The mode transitions are driven by equipment qualification status, quality system state, and safety interlocks — not operator preference.

Five scenarios capture the operational reality:

Normal Production Campaign — 3-day ibuprofen campaign, 6 batches, 16-hour production days. Material Handler verifies raw materials by barcode/RFID. Granulation, compression, coating, packaging with continuous PAT monitoring. Real-time release by QA when all PAT data is within specification.

PAT Sensor Drift — NIR probe triggers suitability alert mid-campaign. Fallback to increased manual HPLC sampling at 70% throughput. Recalibration during planned break. Demonstrates the degraded-mode quality assurance chain.

Containment Breach Emergency — Continuous air monitor detects potent compound (OEL 0.5µg/m³) above action limit during compression. Automatic emergency stop: press de-energises, HVAC to full exhaust, operators evacuate. 8-hour downtime for investigation and corrective action.

Tablet Press Mechanical Jam — Night shift, high-torque alarm, broken punch tip. LOTO, tooling replacement, metal detection check on recent tablets. 90-minute recovery. Demonstrates the mechanical safety and product segregation chain.

Product Changeover — Cytotoxic to Standard — Methotrexate to ibuprofen changeover requiring 3-wash cleaning validation with HPLC swab analysis at 15 worst-case locations. Acceptance limit 0.004µg/cm² derived from toxicological assessment. 16-hour changeover with one re-clean cycle.

Hazard Register

ID	Description	Severity	Freq	SIL	Safe State
H-001	Airborne potent compound exposure from containment breach	Critical	Low	2	Transfer stopped, isolators sealed, HVAC to exhaust, evacuate
H-002	Cross-contamination between drug products during changeover	Catastrophic	Low	3	Batch quarantined, line locked, cleaning validation required
H-003	Dust explosion from pharmaceutical powder exceeding LEL	Catastrophic	Rare	2	Equipment de-energised, N₂ inerting, explosion vents open
H-004	Out-of-specification product released via PAT system failure	Catastrophic	Low	3	Batch quarantined, real-time release suspended, offline QC only
H-005	Loss of cleanroom environmental control	Major	Medium	1	Product exposure points sealed, HVAC dampers close
H-006	Electronic batch record data integrity failure	Critical	Medium	2	System locked, paper backup, affected batches quarantined
H-007	Operator entrapment in tablet press/granulator	Critical	Low	2	Rotating equipment de-energised, mechanically braked, LOTO

Two hazards at SIL 3 (H-002, H-004) will drive the most stringent subsystem requirements — the cleaning validation system and PAT/quality system respectively.

Stakeholders

Role	Relationship	Hex	Key Concern
{{entity:Production Supervisor}}	Operates line, manages batch records	{{hex:018D5AF9}}	OEE, throughput, batch completion
{{entity:Quality Control Analyst}}	Monitors PAT, lab testing, release	{{hex:008D3AF9}}	Product quality, data integrity
{{entity:Pharmaceutical Equipment Maintenance Technician}}	Preventive/corrective maintenance	{{hex:000420F8}}	Equipment reliability, LOTO safety
{{entity:Environmental Health and Safety Officer}}	Containment, emergency response	{{hex:008D38F9}}	Occupational exposure, process safety
{{entity:GMP Material Handler}}	Material receipt, dispensing	{{hex:00050078}}	Material identity, chain of custody
{{entity:FDA/EMA Regulatory Inspector}}	Compliance audit	{{hex:00847AF9}}	GMP compliance, data integrity
Patient	End user of medication	{{hex:00000011}}	Product safety, efficacy, consistency

Operating Environment

Physical: ISO Class 7/8 cleanroom, 18–25°C ±2°C, 30–65% RH, +15Pa differential pressure, 20 ACH with HEPA filtration. Power: 480V 3-phase (tablet press 30kW, coating 50kW, HVAC 200kW), UPS for SCADA/MES/PAT (30min minimum), emergency generator for HVAC and containment. Regulatory: FDA 21 CFR 210/211/11, EU GMP Annex 15, ICH Q8–Q12, ISPE GAMP 5, ATEX 2014/34/EU, IEC 62443. Network: Segregated OT network per ISA/IEC 62443, air-gapped PLCs, MES/ERP via DMZ, 21 CFR Part 11 authentication and audit trail. Operational tempo: 16–24 hour days, campaign length 3–14 days, changeover 8–24 hours, target OEE >70%.

External Interfaces

External System	Interface	Ownership
{{entity:Enterprise Resource Planning System for pharmaceutical plant}} ({{hex:50A57B58}})	Production orders/BOM in, batch records/consumption out, OPC-UA/REST via DMZ	Corporate IT
{{entity:Laboratory Information Management System}} ({{hex:50AD7B58}})	Sample requests out, test results/disposition in, HL7/REST	QC Laboratory
{{entity:Pharmaceutical utilities systems}} ({{hex:54C51058}})	HVAC, purified water (USP), compressed air (ISO 8573-1), N₂, clean steam	Utilities dept
{{entity:Drug serialisation and track-and-trace system}} ({{hex:40E57BD9}})	Serial numbers out, EPCIS events to national registries, EU FMD/US DSCSA	Supply chain

flowchart TB
  PML["Pharmaceutical Manufacturing Line"]
  PS["Production Supervisor"]
  QC["QC Analyst"]
  MT["Maintenance Technician"]
  EHS["EHS Officer"]
  MH["Material Handler"]
  RI["Regulatory Inspector"]
  ERP["ERP System"]
  LIMS["LIMS"]
  UTIL["Building Utilities"]
  SER["Serialisation System"]
  PAT["Patient"]

  PS -->|batch control| PML
  QC -->|quality data, release| PML
  MT -->|maintenance, calibration| PML
  EHS -->|safety oversight| PML
  MH -->|raw materials| PML
  RI -->|audit, inspection| PML
  ERP -->|production orders, BOM| PML
  PML -->|batch records| ERP
  PML -->|sample requests| LIMS
  LIMS -->|test results| PML
  UTIL -->|HVAC, water, air, N2| PML
  PML -->|serial numbers| SER
  PML -->|finished dosage forms| PAT

Next

The scaffold session should derive stakeholder requirements from the five ConOps scenarios, focusing first on the SIL 3 hazards: cross-contamination prevention (H-002) drives cleaning validation subsystem requirements, and OOS product release (H-004) drives PAT subsystem requirements. The containment subsystem (H-001, SIL 2) and dust explosion prevention (H-003, SIL 2) are the next priority. Functional analysis should identify at least: material handling, granulation/blending, compression, coating, in-process quality (PAT), packaging/serialisation, environmental monitoring, containment, MES/batch record, and safety interlock subsystems. The {{trait:Powered}} and {{trait:State-Transforming}} traits dominate this system — cross-domain analogs with chemical process plants and food manufacturing lines should be explored during decomposition.